Screener
Rapport Therapeutics, Inc. RAPP Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Rapport Therapeutics, Inc.’s reported figures.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
FAQ
- What is Rapport Therapeutics, Inc.'s free cash flow?
- Rapport Therapeutics, Inc. (RAPP) reported free cash flow of -$41.53M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s free cash flow changed year-over-year?
- Rapport Therapeutics, Inc.'s free cash flow decreased by 65.5% year-over-year, from -$25.09M to -$41.53M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Rapport Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude